Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
lunes, 29 de marzo de 2010
Porcine-Origin Gentamicin-Resistant Enterococcus faecalis in Humans, Denmark
EID Journal Home > Volume 16, Number 4–April 2010
Volume 16, Number 4–April 2010
Dispatch
Porcine-Origin Gentamicin-Resistant Enterococcus faecalis in Humans, Denmark
Jesper Larsen, Henrik C. Schønheyder, Camilla H. Lester, Stefan S. Olsen, Lone J. Porsbo, Lourdes Garcia-Migura, Lars B. Jensen, Magne Bisgaard, and Anette M. Hammerum
Author affiliations: University of Copenhagen, Frederiksberg, Denmark (J. Larsen, M. Bisgaard); Aarhus University Hospital, Aalborg, Denmark (H.C. Schønheyder); Statens Serum Institut, Copenhagen, Denmark (C.H. Lester, S.S. Olsen, A.M. Hammerum); Technical University of Denmark, Søborg, Denmark (L.J. Porsbo); and Technical University of Denmark, Copenhagen (L. Garcia-Migura, L.B. Jensen)
Suggested citation for this article
Abstract
During 2001–2002, high-level gentamicin-resistant (HLGR) Enterococcus faecalis isolates were detected in 2 patients in Denmark who had infective endocarditis and in pigs and pork. Our results demonstrate that these isolates belong to the same clonal group, which suggests that pigs are a source of HLGR E. faecalis infection in humans.
Infective endocarditis is a life-threatening infection that involves the endocardial surface or vascular structures in proximity to the heart. Its intrinsic resistance to a number of antimicrobial drugs makes enterococcal infective endocarditis cumbersome to treat. For decades, the mainstay has been the combination of a cell wall–active agent (ampicillin, penicillin, or vancomycin) and gentamicin (1). However, high-level resistance to gentamicin hinders the bactericidal activity of combination therapy and increases the likelihood of clinical and microbiologic failure and even death (2).
High-level gentamicin-resistant (HLGR) Enterococcus faecalis has been associated with the hospital setting and prior healthcare exposure, which suggests the existence of a healthcare reservoir (3). Nevertheless, enterococci are gut commensals in humans and warm-blooded animals; therefore, reservoirs of HLGR E. faecalis conceivably might exist in the community not directly linked to the healthcare setting.
During 2000–2002, the proportion of HLGR E. faecalis isolates increased from 2% to 6% in the pig population in Denmark (4–6), which coincided with the emergence of HLGR E. faecalis isolates among patients with infective endocarditis in North Denmark Region. We undertook this study to determine whether pigs are a source of E. faecalis infections in humans.
open here to see the full-text:
http://www.cdc.gov/eid/content/16/4/682.htm
Suggested Citation for this Article
Larsen J, Schønheyder HC, Lester CH, Olsen SS, Porsbo LJ, Garcia-Migura L, et al. Porcine-origin gentamicin-resistant Enterococcus faecalis in humans, Denmark. Emerg Infect Dis [serial on the Internet]. 2010 Apr [date cited]. http://www.cdc.gov/EID/content/16/4/682.htm
DOI: 10.3201/eid1604.090500
No hay comentarios:
Publicar un comentario